Marketing-authorisation holder · Canada
Aralez Pharmaceuticals Canada Inc
12 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
12 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| BLEXTEN10 mg · Tablet (Orally-Disintegrating) | Bilastine | Canada | Marketed | 2022 |
| BLEXTEN6 mg / ml · Solution | Bilastine | Canada | Authorised | |
| BLEXTEN20 mg · Tablet | Bilastine | Canada | Marketed | 2016 |
| BLEXTEN2.5 mg / ml · Solution | Bilastine | Canada | Marketed | 2022 |
| CAMBIA50 mg / sachet · Powder For Solution | Diclofenac | Canada | Marketed | 2012 |
| FIORINAL330 mg + 50 mg + 40 mg · Capsule | Acetylsalicylic acid, Butalbital, Caffeine | Canada | Marketed | 1971 |
| FIORINAL-C 1/2330 mg + 50 mg + 40 mg + 30 mg · Capsule | Acetylsalicylic acid, Butalbital, Caffeine, Codeine | Canada | Marketed | 1970 |
| FIORINAL-C 1/4330 mg + 50 mg + 40 mg + 15 mg · Capsule | Acetylsalicylic acid, Butalbital, Caffeine, Codeine | Canada | Marketed | 1970 |
| MOVIPREP4.7 g / sachet + 100 g / sachet + 1.015 g / sachet + 5.9 g / sachet + 2.691 g / sachet + 7.5 g / sachet · Powder For Solution | Ascorbic acid, Macrogol, Potassium chloride, Sodium chloride, Sodium sulfate anhydrous | Canada | Marketed | 2011 |
| RESULTZ50 % / w/w · Solution | Isopropyl myristate | Canada | Marketed | 2006 |
| SUVEXX500 mg + 85 mg · Tablet | Naproxen, Sumatriptan | Canada | Marketed | 2020 |
| PEGALAX100 % / w/w · Powder For Solution | Macrogol | Canada | Cancelled | 2009 |